The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

M Javle, NJ Curtin - Therapeutic advances in medical …, 2011 - journals.sagepub.com
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

M Javle, NJ Curtin - Therapeutic advances in medical …, 2011 - pubmed.ncbi.nlm.nih.gov
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

M Javle, NJ Curtin - Therapeutic Advances in Medical Oncology, 2011 - eprints.ncl.ac.uk
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …

[引用][C] The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

M Javle, NJ Curtin - Therapeutic Advances in Medical Oncology, 2011 - cir.nii.ac.jp
The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy.

M Javle, NJ Curtin - Therapeutic Advances in Medical Oncology, 2011 - europepmc.org
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …

[HTML][HTML] The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

M Javle, NJ Curtin - Therapeutic Advances in Medical Oncology, 2011 - ncbi.nlm.nih.gov
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

M Javle, NJ Curtin - Therapeutic Advances in …, 2011 - mdanderson.elsevierpure.com
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …

[PDF][PDF] The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

M Javle, NJ Curtin - researchgate.net
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy.

M Javle, NJ Curtin - Therapeutic Advances in Medical …, 2011 - search.ebscohost.com
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy.

M Javle, NJ Curtin - Therapeutic Advances in Medical Oncology, 2011 - europepmc.org
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a
reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is …